|Problem or need||Between 5 and 10% of women of childbearing age suffer a metabolic disorder known as polycystic ovary syndrome or PCOS. Depending on how the condition manifests, they suffer from obesity, infertility and the development of male body characteristics.|
SPIOMET treatment for PCOS normalized post-treatment ovulation rates more frequently than oral contraceptives (OC).
Focusing the treatment of PCOS on the early reduction of hepato-visceral fat may prevent part of the subsequent oligoanovulatory subfertility
- Basic research
- Approval and launch
- Clinical trial / Validation